imaGenes Approved as Agilent Technologies Certified Service Provider

BERLIN, and SANTA CLARA, Calif.

Following a stringent evaluation process, the Berlin-based microarray services specialist imaGenes was officially granted the status as an Agilent Technologies Certified Service Provider (CSP) for Expression Profiling Services, both companies announced today. The CSP status involves the appliance of the entire Agilent microarray workflow, starting from quality controls on Agilent’s bioanalyzer to Agilent reagents, data extraction and analysis software with Genespring GX, documenting high-quality results. imaGenes is offering its services in an ISO 9001:2000-certified environment.

imaGenes’ staff has many years of experience in microarray-based services. One of its core competencies is the establishment of customized solutions, e.g., optimized custom array designs, harmonization of array design, and labeling and hybridization strategy for individual projects as well as extended data analysis and linking of results to verified clone resources.

“The Agilent platform perfectly fits our customers’ requirements by providing flexibility and accuracy,” said Dr. Martina Schad, associate director Microarray Services of imaGenes.

“We’re pleased to welcome imaGenes as a Certified Service Provider,” said Chris Grimley, Agilent senior marketing director, Genomics. "We anticipate synergy between the Agilent microarray-platform and imaGenes’ Next Generation Sequencing service, bioinformatics offerings and corresponding clone resources.
About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.4 billion in fiscal 2007. Information about Agilent is available on the Web at www.agilent.com.

About imaGenes

imaGenes GmbH, Berlin, is a premier provider of genome research services in Europe and was founded in 2007 as a spin-off from RZPD (German Resource Center for Genome Research). imaGenes manages one of the most comprehensive collections of clones of mammalian and vertebrate genes in the world offered via its clone search engine GenomeCube(r), linked to international databases. The second major research services of imaGenes features microarray services on Affymetrix, Agilent, and NimbleGen platforms for a broad range of functional analyses. imaGenes is also offering next generation sequencing services on an Illumina Genome Analyzer System. Researchers in academia and in the pharmaceutical industry are provided with highest quality resources and innovative technology with maximum flexibility and cost effectiveness. imaGenes is fully compliant with ISO 9001:2000 quality standards. A comprehensive overview can be found at www.imagenes-bio.de or www.rzpd.de.